-
公开(公告)号:EP2226074B1
公开(公告)日:2015-11-04
申请号:EP10163998.7
申请日:2007-12-12
申请人: AbbVie Inc.
发明人: Gopalakrishnan, Murali , Honore, Marie P. , Lee, Chih-hung , Malysz, John , Ji, Jianguo , Li, Tao , Schrimpf , Michael R. , Sippy, Kevin B. , Anderson, David J.
IPC分类号: A61K31/4245 , A61K45/06 , A61P25/28
CPC分类号: A61K31/4439 , A61K31/4245 , A61K31/4427 , A61K31/443 , A61K31/444 , A61K31/4709 , A61K45/06 , C07D413/04 , C07D413/14 , G01N33/944 , G01N2333/70571 , A61K2300/00
-
2.PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE 审中-公开
标题翻译: 药剂师ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG公开(公告)号:EP2974727A1
公开(公告)日:2016-01-20
申请号:EP15180552.0
申请日:2007-12-12
申请人: Abbvie Inc.
发明人: Gopalakrishnan, Murali , Honore, Marie P. , Lee, Chih-hung , Malysz, John , Ji, Jianguo , Li, Tao , Schrimpf, Michael R. , Sippy, Kevin B. , Anderson, David J.
IPC分类号: A61K31/4245 , A61K45/06 , A61P25/28 , A61K31/443 , A61K31/444
CPC分类号: A61K31/4439 , A61K31/4245 , A61K31/4427 , A61K31/443 , A61K31/444 , A61K31/4709 , A61K45/06 , C07D413/04 , C07D413/14 , G01N33/944 , G01N2333/70571 , A61K2300/00
摘要: The invention relates to a composition comprising a neuronal nicotinic receptor ligand and an α4β2 positive allosteric modulator, a method of using the same, and a related article of manufacture.
摘要翻译: 本发明涉及包含神经元烟碱型受体配体和±422正变构调节剂的组合物,其使用方法和相关制品。
-
3.N-Biaryl substituted diazabicycloalkane derivatives as agonists of the alpha7 and alpha4beta2 nACh Receptor 审中-公开
标题翻译: N-Biarylsubstituierte Diazabicycloalkanderivate als alpha7 und alpha4beta2 nACh Rezeptor Agonisten公开(公告)号:EP2604611A1
公开(公告)日:2013-06-19
申请号:EP12194563.8
申请日:2008-11-20
申请人: AbbVie Inc.
发明人: JI, Jianguo , LI, Tao , Sippy, Kevin B , Lee, Chih-hung , Gopalakrishnan, Murali
IPC分类号: C07D487/04 , A61K31/407 , A61P25/00
CPC分类号: C07D487/04
摘要: The invention relates to biaryl substituted diazabicycloalkanes of formula (I), and more particularly bicycloheteroaryl substituted fused diazabicycloalkane derivatives, compositions comprising such compounds, and such compounds for use for treating or preventing conditions and disorders related to both α7 and α4β2 nAChR activity Formula: (I).
摘要翻译: 本发明涉及式(I)的联芳基取代的二氮杂双环烷烃,更具体地是双环杂芳基取代的稠合二氮杂双环烷烃衍生物,包含这些化合物的组合物,以及用于治疗或预防与±7和±2 2 nAChR活性相关的病症和障碍的化合物 : (一世)。
-
-